This reagent kit is based on the fluorescence quantitative PCR method, designed with primers and probes targeting the GALV gene. It is equipped with ready-to-use quantitative reference standards for quantitative detection of replicative competent retrovirus RCR in cell therapy products and gene therapy products produced by retroviral vectors.
Product Features:
BP-QN14-100 说明书
[点击下载]+86-756-8699969
Addr.: #333, Pingbei First Road, Nanping Industrial Park, Zhuhai, China 519000
Email:marketing@biori.com